Searched for
SINOVAC AND SINOPHARM
China's Sinovac COVID-19 booster weaker against Omicron: Hong Kong StudySinovac's CoronaVac and state-owned Sinopharm's BBIBP-CorV vaccine are the two most-used vaccines in China.- View: WHO's EUL for Covaxin will play a pivotal role in bridging global vaccine inequalitySome argue that it is not in the interest of existing vaccine manufacturers to have another competitor. However, this is improbable. We are...
- WHO experts back extra Covid jab for people with weak immune systemsMeanwhile, US pharma giant Merck also applied for emergency use authorization of its oral anti-Covid drug in the United States, a major ste...
- China authorises CoronaVac COVID-19 vaccine for children above 3 yearsSinovac has finished the Phase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved t...
- WHO grants emergency approval to 2nd Chinese COVID vaccineIn a statement Tuesday, the U.N. health agency said data submitted to its experts showed that two doses of the vaccine prevented people fro...
- View: There's a way out of the vaccine crunch India faces: Dial ChinaPoliticians of all hues will find it hard to suddenly advocate vaccines from Sinopharm and Sinovac Biotech Ltd. Yet what can be a bigger na...
- Chinese companies considers mixing vaccines, booster shotsSinovac and Sinopharm, the two Chinese manufacturers that combined have exported hundreds of millions of doses all over the world, say they...
- WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccinesSo far COVID-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing - an endorsement of their safety and ...
- WHO vaccine experts say Chinese jabs show 'safety', but data lackingThe vaccines demonstrated safety and good efficacy against symptomatic Covid-19 disease but both vaccines lacked data in older age groups a...
- Sinovac says its vaccine is safe for children as young as 3There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-ye...
- Alleged Chinese hand: Sri Lanka approves Sinopharm vaccine for emergency useThe approval was granted by National Medicines Regulatory Authority, State Minister of Production, Supply and Regulation of Pharmaceuticals...
- China gives approval for broader use of Sinovac vaccineRegulators gave conditional approval for Sinovac Biotech Ltd's shot, CoronaVac, on Friday, clearing the way for general use, The National M...
- China approves second domestic Covid-19 vaccineThe vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use ...
- China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
- Explainer: What's behind varying efficacy data for Sinovac's coronavirus vaccine?Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...
- China to vaccinate 50 million people for Lunar New Year - SCMPChina has granted emergency-use status to two candidate vaccines from Sinopharm and one from Sinovac Biotech. It has approved a fourth, fro...
- UAE starts Covid-19 vaccinations in capitalThe wealthy Gulf nation is one of the first countries to start widespread inoculation, after Britain became the first to roll out a campaig...
- China prepares large-scale rollout of COVID-19 vaccinesDevelopers are speeding up final testing, the Chinese foreign minister said Thursday during a U.N. meeting, as Britain issued approval for ...
- China shows off Covid-19 vaccines for the first time, makers stay hopefulChina, which is facing a storm of foreign criticism over its early handling of the pandemic, has been trying to repurpose the story of Covi...
- The four front runners of the race for Covid vaccineThe vaccines for the deadly Covid-19 are in various stages of trial. ET takes a look at four vaccine candidates, where the results of the c...
Load More
